In cancer, inflammaging fosters uncontrolled cell proliferation and tumor aggressiveness through a chronic inflammatory environment that continually activates NF-κB and elevates IL-1α, enhancing tumor immune suppression and affecting cancer progression (M et al., 2024; Olivieri et al., 2013). This evidence concerns the gene NFKB1 and cancer.